• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种可消除小儿房间隔缺损封堵术后长期壁侵蚀风险的策略。

A strategy for atrial septal defect closure in small children that eliminates long-term wall erosion risk.

机构信息

Division of Pediatric Cardiology, Department of Pediatrics, Duke University Medical Center, Durham, North Carolina 27710, USA.

出版信息

Catheter Cardiovasc Interv. 2013 Mar;81(4):654-9. doi: 10.1002/ccd.24500. Epub 2012 Nov 14.

DOI:10.1002/ccd.24500
PMID:22639441
Abstract

OBJECTIVES

To evaluate feasibility, efficacy, and safety of an approach to atrial septal defect (ASD) occlusion in children ≤20 kg that eliminates cardiac wall erosion risk.

BACKGROUND

Cardiac wall erosion is a potentially catastrophic complication of ASD device closure. The HELEX Septal Occluder (HSO) is a compliant device with no reports of erosion. The HSO is technically difficult to deploy in smaller children and cannot be used to close larger defects. To eliminate wall erosion risk, we use the HSO when feasible and surgery for larger defects.

METHODS

Retrospective review of ASD procedures performed in children ≤20 kg.

RESULTS

Between January 2006 and January 2011, 60 children underwent ASD closure. HSO placement was successful in 32 of 34 patients, and surgical closure was successful in all of 28 patients. Surgical patients were younger (35.1 ± 12.6 vs. 47.4 ± 15.3 months, P < 0.01) and smaller (15.3 ± 3.2 vs. 12.6 ± 4.3 kg; P < 0.01) with larger ASDs (15.8 ± 4.5 vs. 9.8 ± 3.0 mm; P < 0.01). No surgical patients demonstrated residual leak. Residual leak was seen in 14 of 32 (44%) HSO patients on postprocedure day #1 and in 1 of 26 (3.8%) with ≥6 months follow-up. Indications for surgery included: deficient inferior/superior rims (n = 17), provider preference (n = 2), and HSO device not feasible (n = 9). Serious adverse events included device embolization with percutaneous retrieval (n = 1) and postpericardiotomy syndrome without intervention (n = 1).

CONCLUSIONS

The HSO can be safely used in most children ≤20 kg. Our approach to ASD closure is associated with minimal morbidity and good short-term results. This approach requires no more than a 15% increase in surgical referrals and eliminates risk of cardiac wall erosion.

摘要

目的

评估一种用于 ≤20kg 儿童房间隔缺损(ASD)封堵的方法的可行性、疗效和安全性,该方法可消除心脏壁侵蚀的风险。

背景

心脏壁侵蚀是 ASD 装置封堵的一种潜在灾难性并发症。HELEX Septal Occluder(HSO)是一种顺应性装置,尚无侵蚀的报道。在较小的儿童中,HSO 的技术难度较大,无法用于封堵较大的缺损。为了消除壁侵蚀风险,对于较小的缺损,我们尽可能使用 HSO,对于较大的缺损,则采用手术。

方法

回顾性分析 20kg 以下儿童 ASD 手术的病例。

结果

2006 年 1 月至 2011 年 1 月,共有 60 名儿童接受 ASD 封堵术。34 名患者中,HSO 放置成功 32 例,28 名患者手术成功。手术组患者年龄较小(35.1±12.6 个月 vs. 47.4±15.3 个月,P<0.01)、体重较轻(15.3±3.2kg vs. 12.6±4.3kg,P<0.01),ASD 较大(15.8±4.5mm vs. 9.8±3.0mm,P<0.01)。无手术患者有残余漏。HSO 患者在术后第 1 天有 14 例(44%)和 26 例中有 1 例(3.8%)在≥6 个月随访时存在残余漏。手术的适应证包括:下/上缘缺陷(n=17)、术者偏好(n=2)和 HSO 装置不可行(n=9)。严重不良事件包括经皮取出的器械栓塞(n=1)和无需干预的心包切开术后综合征(n=1)。

结论

HSO 可安全用于大多数≤20kg 的儿童。我们的 ASD 封堵方法具有较低的发病率和良好的短期效果。该方法只需要增加不超过 15%的手术转诊率,且可消除心脏壁侵蚀的风险。

相似文献

1
A strategy for atrial septal defect closure in small children that eliminates long-term wall erosion risk.一种可消除小儿房间隔缺损封堵术后长期壁侵蚀风险的策略。
Catheter Cardiovasc Interv. 2013 Mar;81(4):654-9. doi: 10.1002/ccd.24500. Epub 2012 Nov 14.
2
Device therapy for atrial septal defects in a multicenter cohort: acute outcomes and adverse events.多中心队列中房间隔缺损的器械治疗:急性结局和不良事件
Catheter Cardiovasc Interv. 2015 Feb 1;85(2):227-33. doi: 10.1002/ccd.25684. Epub 2014 Oct 13.
3
Percutaneous atrial septal occluder devices and cardiac erosion: a review of the literature.经皮房间隔封堵器装置与心脏侵蚀:文献复习。
Catheter Cardiovasc Interv. 2012 Aug 1;80(2):157-67. doi: 10.1002/ccd.24347. Epub 2012 May 2.
4
Results of the U.S. multicenter pivotal study of the HELEX septal occluder for percutaneous closure of secundum atrial septal defects.美国关于用于经皮闭合继发孔型房间隔缺损的HELEX房间隔封堵器的多中心关键研究结果。
J Am Coll Cardiol. 2007 Jun 5;49(22):2215-21. doi: 10.1016/j.jacc.2006.11.053. Epub 2007 May 9.
5
Transcatheter closure of large atrial septal defects: feasibility and safety in a large adult and pediatric population.经导管闭合大型房间隔缺损:在大型成人和儿科人群中的可行性和安全性。
Circ Cardiovasc Interv. 2014 Dec;7(6):837-43. doi: 10.1161/CIRCINTERVENTIONS.113.001254. Epub 2014 Nov 25.
6
Transcatheter closure of atrial septal defects in children and adolescents: single-center experience with the GORE® septal occluder.儿童及青少年房间隔缺损的经导管封堵术:使用戈尔®房间隔封堵器的单中心经验
Catheter Cardiovasc Interv. 2014 Nov 15;84(6):E51-7. doi: 10.1002/ccd.25494. Epub 2014 Aug 6.
7
Surgical perspective of percutaneous device closure of atrial septal defect.房间隔缺损经皮器械封堵术的外科视角
Asian Cardiovasc Thorac Ann. 2018 Jun;26(5):343-346. doi: 10.1177/0218492318776568. Epub 2018 May 2.
8
Long-term follow-up of the STARFlex device for closure of secundum atrial septal defect.STARFlex装置封堵继发孔房间隔缺损的长期随访
Catheter Cardiovasc Interv. 2009 Feb 1;73(2):190-5. doi: 10.1002/ccd.21710.
9
Midterm follow-up of percutaneous closure of secundum atrial septal defect with Helex Septal Occluder.
J Interv Cardiol. 2008 Aug;21(4):363-8. doi: 10.1111/j.1540-8183.2008.00365.x. Epub 2008 Jun 28.
10
Mid-term outcomes of the Helex septal occluder for percutaneous closure of secundum atrial septal defects.用于经皮闭合继发孔型房间隔缺损的Helex房间隔封堵器的中期疗效
Congenit Heart Dis. 2013 Sep-Oct;8(5):428-33. doi: 10.1111/chd.12043. Epub 2013 Mar 1.